Bank Vontobel AG Stock

RMAS7V

CH1315861554

Market Closed - Swiss Exchange 11:20:00 2024-07-11 am EDT
99.2 ^USD	+0.51%

Current month	+0.30%
1 month	+1.54%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $50 From $54, Maintains Neutral Rating	07:57am	MT
Barclays Adjusts Price Target on Bristol-Myers Squibb to $41 From $43	Jul. 10	MT
Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day	Jul. 08	BU
Ex-dividend day	Jul. 04	FA

More news

Quotes 5-day view

Date	Price	Change
24-07-11	99.2	+0.51%
24-07-10	98.7	+0.61%
24-07-03	98.1	-0.51%

Delayed Quote Swiss Exchange

Last update July 11, 2024 at 11:20 am EDT

More quotes

Static data

Product type	Reverse Convertibles
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Vontobel
	RMAS7V
ISIN	CH1315861554
Date issued	2024-03-01
Strike	50.89 $
Maturity	2025-09-02 (418 Days)
Parity	0.05 : 1
Emission price	100 $
Emission volume	N/A
Settlement	both
Currency	USD

Technical Indicators

Highest since issue	101 $
Lowest since issue	97 $
Spread	10 $
Spread %	1.00%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.12 USD

Average target price

52.92 USD

Spread / Average Target

+28.70%

Consensus